NCT02436941Enrolling by invitation
Radiation Medicine Patient Registry, Loma Linda University Medical Center
Loma Linda University Medical Center Department of Radiation Medicine Patient Registry
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
For most cancers, long-term follow-up is the best measure of treatment effectiveness. The Department of Radiation Medicine at Loma Linda University Medical Center operates the James M. Slater, M.D., Proton Treatment and Research Center, the world's first hospital-based proton treatment facility. Patients have been treated at the Center since 1990. Radiation treatment has been expanded and refined since the Center's opening, and these changes have been based primarily on outcomes seen and evaluated in long-term follow-up. The Radiation Medicine Patient Registry (a multi-year database), which began as an IRB-approved study in 2003, including detailed follow-up of study data collected from 1990 and onward, is designed to track all medical information from patients treated with proton therapy and/or conventional X-ray therapy at Loma Linda University Medical Center. Information gathered from patients treated years or even decades ago helps to determine the most effective use of proton and conventional radiation in caring for patients with cancers and other diseases.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 75000 (estimated)
- First submitted
- 27 Mar 2015
- Start date
- 20 Oct 2003
- Primary completion date
- 31 Mar 2040
- Lead sponsor
- Loma Linda University
- Diseases
- Childhood cancers
- NCT number
- NCT02436941
What you commit to
- Study type: Observational
- Planned participants: 75000
- From 20 Oct 2003 to the primary completion date, 31 Mar 2040
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- There are no specific exclusion criteria, but patients who are unwilling to sign the ICD will not be included
Who the study is looking for
- Diagnosis of benign or malignant tumors or other conditions deemed treatable by proton or conventional photon radiotherapy
- Willingness to sign an Informed Consent Document
Age in the registry: - to 99 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.